Wednesday, December 30, 2020

Glenmark Pharma gets USFDA nod for erectile dysfunction treatment drug

Glenmark Pharma gets USFDA nod for erectile dysfunction treatment drug Glenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Tadalafil tablets USP in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3hzEsrl
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FIIs ease bearish bets post-Budget, but charts warn of range-bound Nifty: Anand James

Foreign investors are reducing their negative bets on the market after the Budget. However, the market's overall sentiment remains delic...